好男人www-91视频免费播放-日本va欧美va精品发布-亚洲成人精品久久-亚洲情射-中国国产毛片-蜜桃臀av在线-欧美日韩激情一区-伊人95-18欧美性xxxx极品hd-黄www在线观看

技術文章您現在的位置:首頁 > 技術文章 > 一種源自 Hungatella hathewayi 的分泌蛋白通過重編程瘤內CD14b+巨噬細胞抑制結直腸癌

一種源自 Hungatella hathewayi 的分泌蛋白通過重編程瘤內CD14b+巨噬細胞抑制結直腸癌

更新時間:2026-09-19   點擊次數:67次

中文摘要:

腸道菌群與結直腸癌(CRC)的發生發展密切相關。本研究發現,H. hathewayi——一種此前被報道與CRC相關的共生菌——在自發性CRC模型中反而對腸道腫瘤生長和腸道菌群失調具有保護作用。H. hathewayi可減緩同種異體移植結腸癌細胞的生長,并抑制ApcMin/+ 小鼠的CRC進展,同時伴隨瘤內 CD14b+ 腫瘤相關巨噬細胞(TAMs)增多。這種保護效應歸因于 H. hathewayi 分泌至 Hh.CM 中的蛋白,我們鑒定出一種含細胞壁結合重復序列的蛋白(CWBR-CP)是關鍵功能介質。CWBR-CP 在多種小鼠模型中重現了 H. hathewayi 的抑瘤效果,并誘導巨噬細胞向 M1 樣極化轉變。機制上,CWBR-CP 直接結合激肽釋放酶 8(KLK8)并下調其在巨噬細胞中的表達。KLK8 的下調進而激活緩激肽受體 B1(B1R),觸發 PI3K/AKT/NF-κB 通路,最終促進 M1 型巨噬細胞極化。



英文摘要:

Gut microbiota has been widely implicated in colorectal cancer (CRC). Here, we show that H. hathewayi, a commensal bacterium previously associated with CRC, is protective against intestinal tumor growth, and gut dysbiosis in a spontaneous CRC model. H. hathewayi attenuated the growth of allografted colon carcinoma cells and suppressed CRC progression in ApcMin/+ mice, concomitant with an increased intratumoral CD14b+ tumor-associated macrophages (TAMs). Such protective effect was attributed to H. hathewayi-secreted proteins from Hh.CM, and we identified a cell wall-binding repeat-containing protein (CWBR-CP) as the key functional mediator. CWBR-CP recapitulated the tumor suppression of H. hathewayi in multiple mouse models and induced a corresponding shift toward M1-like macrophage polarization. Mechanistically, CWBR-CP directly bound to kallikrein 8 (KLK8) and downregulated its expression in macrophages. KLK8 downregulation, in turn, activated bradykinin receptor B1 (B1R), triggering the PI3K/AKT/NF-κB pathway and ultimately promoting M1 macrophage polarization.



論文信息:

論文題目:A secreted protein from Hungatella hathewayi inhibits colorectal cancer by reprogramming intratumoral CD14b+ macrophages

期刊名稱:Cell Reports

時間期卷:Volume 45, Issue 9, 117988

在線時間:2026年9月9日

Doi:10.1016/j.celrep.2026.117988

產品信息:

貨號:CP-010-010

規格:10ml+10ml

品牌:Liposoma

產地:荷蘭

名稱:Clodronate Liposomes&Control Liposomes

辦事處:靶點科技


Clodronate Liposomes氯膦酸鹽脂質體清除APC-Min 小鼠巨噬細胞,APC-Min 小鼠是攜帶 Apc 基因多發性腸道腫瘤(Min)突變的雜合小鼠。純合小鼠會致死。 這種小鼠能自發產生 腸道腺瘤,并在生存、生長、攝食量和 腸道病變 等方面表現出 腸癌疾病 的特征。 因此,APC-Min 小鼠可用于研究家族性腺瘤息肉病(FAP)、結直腸癌等腫瘤或腫瘤相關疾病,以及 Wnt/β-catenin 信號通路的調控機制。荷蘭Liposoma巨噬細胞清除劑ClodronateLiposomes見刊于Cell Reports:一種源自 Hungatella hathewayi 的分泌蛋白通過重編程瘤內CD14b+巨噬細胞抑制結直腸癌。

一種源自 Hungatella hathewayi 的分泌蛋白通過重編程瘤內CD14b+巨噬細胞抑制結直腸癌




Liposoma巨噬細胞清除劑Clodronate Liposomes氯膦酸二鈉脂質體清除巨噬細胞的材料和方法:

In vivo macrophage depletion

For the macrophage depletion model, male ApcMin/+ mice were orally gavaged with an oral administration of live H. hathewayi (1.0 × 108 CFU per mouse) in 0.1 mL sterile saline containing 2.5% glycerol for 9 weeks (n = 6). During this process, the mice were injected (i.p) with PBS liposomes and clodronate liposomes (LIPOSOMA) every two weeks and body weight and bleeding score were assessed daily.



巨噬細胞清除材料和方法文獻截圖:

一種源自 Hungatella hathewayi 的分泌蛋白通過重編程瘤內CD14b+巨噬細胞抑制結直腸癌


靶點科技(北京)有限公司

靶點科技(北京)有限公司

地址:中關村生命科學園北清創意園2-4樓2層

© 2026 版權所有:靶點科技(北京)有限公司  備案號:京ICP備18027329號-2  總訪問量:477813  站點地圖  技術支持:化工儀器網  管理登陸